Volume 69, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Antibodies of all four dengue virus serotypes were detected by hemagglutination inhibition (HI) in 97% of 2,000 infants’ cord sera at the time of delivery. In comparison with 250 mother–infant’s paired sera, we found that 53% of the infants’ serum HI titers were higher than those of the mother’s. The mother/infant IgG subclasses 1, 2, 3, and 4 titers were 53.1/87.0, 8.4/11.7, 0.14/0.11, and 1.1/1.0 mg/dL, respectively. In 18 months of follow-up of 100 infants studied, we observed that antibody to dengue virus disappeared in 3% by two months of age, in 19% by four months of age, in 72% by six months of age, in 99% by nine months of age, and in 100% by 12 months of age, with a half-life of 41 days. We conclude that the antibodies to dengue virus disappeared in the first year of life. We suggest that the most appropriate age for vaccination with a live-attenuated dengue vaccine in an endemic area is one year of age.


Article metrics loading...

Loading full text...

Full text loading...



  1. Tsai TF, 2000. Flaviviviruses (Yellow Fever, Dengue, Dengue Hemorrhagic Fever, Japanese Encephalitis, St. Louis Encephalitis, Tick-Borne Encephlitis). Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Fifth edition. Philadelphia: Churchill Livingstone, 1714–1736.
  2. Henchal EA, Putnak JR, 1990. The dengue viruses. Clin Microbiol Rev 3 : 376–396.
  3. Epidemiologic Department, Ministry of Public Health, Thailand, 1998. Annual Epidemiological Surveillance Report.
  4. Halstead SB, 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42 : 350–362.
  5. Gubler DJ, 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11 : 480–496.
  6. Rothman AL, Ennis FA, 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257 : 1–6.
  7. Kliks SC, Nimmanitya S, Nisalak A, Burke DS, 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38 : 411–419.
  8. Taura Y, Fujiyama S, Kawano S, Sato S, Tanaka M, Goto M, Chikazawa H, Shibata J, Mizuno K, Sato T, 1995. Clinical evaluation of titration of hepatitis C virus core antibody and its subclasses. J Gastroenterol Hepatol 10 : 270–276.
  9. Ljunggren K, Broliden PA, Morfeldt-Manson L, Jondal M, Wahren B, 1988. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin Exp Immunol 73 : 343–347.
  10. Slifka MK, Matloubian M, Ahmed R, 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 69 : 1895–1902.
  11. Smucny JJ, Kelly EP, Macarthy PO, King AD, 1995. Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein. Am J Trop Med Hyg 53 : 432–437.
  12. Hutchins WA, Carlone GM, Westerink MA, 1999. Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. J Infect Dis 179 : 1433–1440.
  13. Brandenburg AH, Groen J, Steensel-Moll HA, Claas ES, Rothbarth PH, Neijens HJ, Osterhaus AD, 1997. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 52 : 97–104.
  14. Trlifajova J, Pokorny J, Svandova E, Ryba M, 1982. Study of persistence of maternal antibodies to varicella-zoster virus by indirect haemagglutination, with result control by radioimmunoassay. J Hyg Epidemiol Microbiol Immunol 26 : 65–73.
  15. Jansson M, Wahren B, Scarlatti G, Principi N, Lombardi V, Livadiotti S, Elia L, Plebani A, Wigzell H, Rossi P, 1992. Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers. AIDS 6 : 365–371.
  16. Clarke DH, Casals J, 1958. Techniques for hemagglutination and hemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7 : 561–573.
  17. Russell PK, Nisalak A, 1967. Dengue virus identification by the plaque reduction neutralization test. J Immunol 99 : 291–296.
  18. Russell PK, Nisalak A, Sukhavachana P, Vivona S, 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99 : 285–290.
  19. Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S, 1991. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 44 : 481–493.
  20. Towbin H, Staehelin T, Gordon J, 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76 : 4350–4354.
  21. Landor M, 1995. Maternal-fetal transfer of Immunoglobulins. Ann Allergy Asthma Immunol 74 : 279–283.
  22. van Furth R, Schuit HR, Hijmans W, 1965. The immunological development of the human fetus. J Exp Med 122 : 1173–1188.
  23. Gitlin D, Kumate J, Morales C, Noriega L, Arevalo N, 1972. The turnover of amniotic fluid protein in the human conceptus. Am J Obstet Gynecol 113 : 632–645.
  24. Ventura AK, Ehrenkranz NJ, Rosenthal D, 1975. Placental passage of antibodies to dengue virus in persons living in a region of hyperendemic dengue virus infection. J Infect Dis 131 : S62–S68.
  25. Singh J, Khare S, Prabha S, Chandra R, Jain DC, Bhatia R, Sokhey J, 1998. Transplacental transfer of measles antibody in Delhi. Indian Pediatr 35 : 1187–1191.
  26. Griffiths PD, Girdhar D, Fisher-Hoch S, Race MW, Heath RB, 1984. Antibody against viruses in maternal and cord sera: non-specific inhibitors are found to higher titre on the maternal side of the circulation. J Hyg (London) 92 : 297–301.
  27. Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M, Ringwald P, Cot M, 1997. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol 110 : 212–218.
  28. Gitlin D, Biasucci A, 1969. Development of gamma G, gamma A, gamma M, beta IC-beta IA, C1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus. J Clin Invest 48 : 1433–1446.
  29. Schur PH, Alpert E, Alper C, 1973. Gamma G subgroups in human fetal, cord, and maternal sera. Clin Immunol Immuno-path 2 : 62–66.
  30. Pitcher-Wilmott RW, Hindocha P, Wood CB, 1980. The placental transfer of IgG subclasses in human pregnancy. Clin Exp Immunol 41 : 303–308.
  31. Malek A, Sager R, Zakher A, Schneider H, 1994. Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta. Am J Obstet Gynecol 173 : 760–767.
  32. Wang AC, Faulk WP, Stuckey MA, Fudenberg HH, 1970. Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry 7 : 703–708.
  33. Hay FC, Hull MG, Torrigiani G, 1971. The transfer of human IgG subclasses from mother to foetus. Clin Exp Immunol 9 : 355–358.
  34. Virella G, Silveira-Nunes MA, Tamagnini G, 1972. Placental transfer of human IgG subclasses. Clin Exp Immunol 10 : 475–478.
  35. Morell A, Skvaril F, Hitzig WH, Barandun S, 1972. IgG subclasses: development of the serum concentrations in “normal” infants and children. J Pediatr 80 : 960–964.
  36. Asano Y, Hiroishi Y, Itakura N, Hirose S, Kajita Y, Suga S, Yazaki T, 1988. Placental transfer of IgG subclass-specific antibodies to varicella-zoster virus. J Med Virol 26 : 1–6.
  37. Einhorn MS, Granoff DM, Nahm MH, Quinn A, Shackelford PG, 1987. Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr 111 : 783–788.
  38. Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD, 1994. Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol 1 : 667–669.
  39. Morell A, Terry WD, Walmann TA, 1970. Metabolic properties of IgG subclasses in man. J Clin Invest 49 : 673–680.
  40. Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA, 1979. Transfer of measles, mumps and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child 133 : 1240–1243.
  41. Sennhauser FH, Balloch A, Macdonold RA, Shelton MJ, Roberton DM, 1990. Maternofetal transfer of IgG anti-Escherichia coli antibodies with enhanced avidity and opsonic activity in very premature neonates. Pediatr Res 27 : 365–371.
  42. Jefferis R, Kumararatne DS, 1990. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 81 : 357–367.
  43. van der Zee JS, van Swieten P, Aalberse RC, 1986. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 64 : 415–422.
  44. Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A, 1993. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol 40 : 102–106.
  45. Rosen L, 1986. Dengue in Greece in 1927 and 1928 and the pathogenesis of dengue hemorrhagic fever: new data and a different conclusion. Am J Trop Med Hyg 35 : 642–653.
  46. Rosen L, 1958. Observations on the epidemiology of dengue in Panama. Am J Hyg 68 : 45–58.
  47. Halstead SB, 1974. Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg 23 : 974–982.
  48. Vaughn DW, Hoke CH Jr, Yoksan S, LaChance R, Innis BL, Rice RM, Bhamarapravati N, 1996. Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers. Vaccine 14 : 329–336.

Data & Media loading...

  • Received : 16 Jan 2003
  • Accepted : 24 Mar 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error